ALGN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Align Technology Inc (ALGN) is a good buy for a beginner investor with a long-term investment strategy and $50,000-$100,000 available for investment. The company's strong Q4 financial performance, positive analyst sentiment, and improving fundamentals in the dental space outweigh the lack of recent trading signals and neutral technical indicators. The stock's recent price levels and long-term growth prospects make it a suitable choice for the user's investment profile.
The technical indicators are mixed. The MACD histogram is below 0 and negatively contracting, suggesting bearish momentum. However, the RSI is neutral at 58.284, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 187.209, with support at 178.15 and resistance at 196.267. Overall, the technicals do not provide a strong directional signal but indicate stability.
Strong Q4 financial performance with revenue up 5.26% YoY, net income up 30.78% YoY, and EPS up 35.97% YoY.
Positive analyst sentiment, with multiple upgrades and increased price targets from firms like HSBC, Baird, and Piper Sandler.
Encouraging growth in adult aligner shipments and international strength.
Long-term profitability improvements expected through 3D printing and operational efficiencies.
Gross margin dropped by 6.81% YoY in Q4, indicating potential cost pressures.
Lack of recent news or event-driven catalysts.
Neutral trading sentiment from hedge funds and insiders.
Options data suggests bearish sentiment with a high Option Volume Put-Call Ratio of 4.27.
In Q4 2025, Align Technology reported strong financial performance: Revenue increased by 5.26% YoY to $1.047 billion, net income rose by 30.78% YoY to $135.76 million, and EPS grew by 35.97% YoY to 1.89. However, gross margin declined to 65.26%, down 6.81% YoY.
Analysts are generally positive on ALGN. Recent upgrades include HSBC upgrading the stock to Buy with a price target of $200, citing growth in adult aligner shipments and improving sentiment in the dental space. Baird, Piper Sandler, and Stifel have also raised price targets, with Piper Sandler noting a wide EPS beat and balanced growth across aligners and scanners. The average price target is around $200-$220, reflecting optimism for long-term growth.
